Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Mental Health in Multiple Sclerosis Patients without Limitation of Physical Function: The Role of Physical Activity.
Use of Fingolimod in the Management of Relapsing-Remitting Multiple Sclerosis: Experience from Latin America.
Recommendations for observational studies of comorbidity in multiple sclerosis.
Epigenetic in Multiple Sclerosis: Molecular mechanisms and dietary intervention.
Tamoxifen administration immediately or 24 hours after spinal cord injury improves locomotor recovery and reduces secondary damage in female rats.
Development of oral agent in the treatment of multiple sclerosis: how the first available oral therapy, fingolimod will change therapeutic paradigm approach.
Relapses in multiple sclerosis: effects of high-dose steroids on cortical excitability.
The detection of THC, CBD and CBN in the oral fluid of Sativex(®) patients using two on-site screening tests and LC-MS/MS.
Systematic review and meta-analysis of pharmacological therapies for pain associated with postherpetic neuralgia and less common neuropathic conditions.
Recent onset disequilibrium mimicking acute vestibulopathy in early multiple sclerosis.
Current and future potential of retinal optical coherence tomography in multiple sclerosis with and without optic neuritis.
Effects of Bacille Calmette-Guérin after the first demyelinating event in the CNS.
Serum anticardiolipin antibodies in patients with neuromyelitis optica spectrum disorder.
Factors affecting bone mineral density in multiple sclerosis patients.
Intrathecal immune reset in multiple sclerosis: Exploring a new concept.
Interferon-beta-induced pulmonary sarcoidosis in a 30-year-old woman treated for multiple sclerosis: a case report.
Protein-protein interaction analysis highlights additional Loci of interest for multiple sclerosis.
Targeting B cells in the treatment of multiple sclerosis: recent advances and remaining challenges.
Costs and quality of life in multiple sclerosis patients with spasticity.
Venous hemodynamics in neurological disorders: an analytical review with hydrodynamic analysis.
Remyelination in multiple sclerosis: realizing a long-standing challenge.
Changes in Methionine Metabolism and Histone H3 Trimethylation Are Linked to Mitochondrial Defects in Multiple Sclerosis.
Underrecognition of Sleep Disorders in Patients with Multiple Sclerosis.
Ipilimumab in patients with melanoma and autoimmune disease.
Detection of protein aggregates in brain and cerebrospinal fluid derived from multiple sclerosis patients.
Pages
« first
‹ previous
…
561
562
563
564
565
566
567
568
569
…
next ›
last »